Panacea Biotec
-
{
- All
- News
- Videos
-
Stocks To Watch: Bajaj Finance, Gensol Engineering, Biocon And More
Stock like Central Bank of India, Adani Green and NHPC are set to see action going into trade on Thursday.
-
Panacea Biotec Shares Jump Over 5% After Announcement Of Baby Diaper Brand
The baby diaper brand will cater to the domestic market at present, but Panacea Biotec has plans to sell the products in other countries in 'due course'.
-
Panacea Biotec Shares Jump Over 5% After Announcement Of Baby Diaper Brand
The baby diaper brand will cater to the domestic market at present, but Panacea Biotec has plans to sell the products in other countries in 'due course'.
-
Panacea Biotec Hits Highest Level In Over Three Years As Company Settles Patent Dispute With Sanofi
The dispute involved Panacea Biotec’s patented vaccine, EasySix, the first fully liquid hexavalent vaccine used for treatment of polio, tetanus, and diphtheria.
-
Panacea Biotec, Sanofi Settle Patent Dispute Over Hexavalent Vaccine
Panacea Biotec initially filed the lawsuit in May 2021, seeking to stop Sanofi from marketing its Shan6 vaccine, which it believed infringed on Panacea’s patent for its wP-IPV based EasySix vaccine.
-
Panacea Biotec Surges 7% As FDA Clears Solan Facility
Shares of Panacea Biotec surged as much as 6.76 per cent to hit intraday high of Rs 112.80 in an otherwise weak market after the US drug regulator (USFDA) gave its Establishment Inspection Report (EIR) for the Indian drugmaker's facilities in Solan, Himachal Pradesh.
-
Panacea Biotec Rallies 9% On Receiving License To Produce Sputnik V Vaccine
The Sputnik V vaccine will be produced at Panacea Biotec's Baddi manufacturing facility in Himachal Pradesh.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
U.S. FDA Flags Nine Lapses At Panacea Biotech’s Baddi Facility
Form 483 was issued with nine observations "which are related to improvements in existing procedures," the company said.
-
Sensex, Nifty Fall Most In Two Weeks Dragged By Metals, I.T., Realty Stocks; FPIs Stay Net Sellers
Live updates from India's equity markets on Oct. 11.
-
Sensex, Nifty Fall Most In Two Weeks Dragged By Metals, I.T., Realty Stocks; FPIs Stay Net Sellers
Live updates from India's equity markets on Oct. 11.
-
Panacea Biotec Hits Upper Circuit After Winning Rs 1,000-Crore Vaccine Order
Panacea Biotec has bagged orders worth Rs 1,040 crore from the Unicef and Pan American Health Organization.
-
Panacea Biotec Hits Upper Circuit After Winning Rs 1,000-Crore Vaccine Order
Panacea Biotec has bagged orders worth Rs 1,040 crore from the Unicef and Pan American Health Organization.
-
Panacea Biotec Shares Gain On Sale Of Domestic Formulations Brands To Mankind
Panacea Biotec Pharma has agreed to sell its formulations brands in India and Nepal to Mankind.
-
Panacea Biotec Rallies 9% On Receiving License To Produce Sputnik V Vaccine
The Sputnik V vaccine will be produced at Panacea Biotec's Baddi manufacturing facility in Himachal Pradesh.
-
Stocks To Watch: Bajaj Finance, Gensol Engineering, Biocon And More
Stock like Central Bank of India, Adani Green and NHPC are set to see action going into trade on Thursday.
-
Panacea Biotec Shares Jump Over 5% After Announcement Of Baby Diaper Brand
The baby diaper brand will cater to the domestic market at present, but Panacea Biotec has plans to sell the products in other countries in 'due course'.
-
Panacea Biotec Shares Jump Over 5% After Announcement Of Baby Diaper Brand
The baby diaper brand will cater to the domestic market at present, but Panacea Biotec has plans to sell the products in other countries in 'due course'.
-
Panacea Biotec Hits Highest Level In Over Three Years As Company Settles Patent Dispute With Sanofi
The dispute involved Panacea Biotec’s patented vaccine, EasySix, the first fully liquid hexavalent vaccine used for treatment of polio, tetanus, and diphtheria.
-
Panacea Biotec, Sanofi Settle Patent Dispute Over Hexavalent Vaccine
Panacea Biotec initially filed the lawsuit in May 2021, seeking to stop Sanofi from marketing its Shan6 vaccine, which it believed infringed on Panacea’s patent for its wP-IPV based EasySix vaccine.
-
Panacea Biotec Surges 7% As FDA Clears Solan Facility
Shares of Panacea Biotec surged as much as 6.76 per cent to hit intraday high of Rs 112.80 in an otherwise weak market after the US drug regulator (USFDA) gave its Establishment Inspection Report (EIR) for the Indian drugmaker's facilities in Solan, Himachal Pradesh.
-
Panacea Biotec Rallies 9% On Receiving License To Produce Sputnik V Vaccine
The Sputnik V vaccine will be produced at Panacea Biotec's Baddi manufacturing facility in Himachal Pradesh.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
U.S. FDA Flags Nine Lapses At Panacea Biotech’s Baddi Facility
Form 483 was issued with nine observations "which are related to improvements in existing procedures," the company said.
-
Sensex, Nifty Fall Most In Two Weeks Dragged By Metals, I.T., Realty Stocks; FPIs Stay Net Sellers
Live updates from India's equity markets on Oct. 11.
-
Sensex, Nifty Fall Most In Two Weeks Dragged By Metals, I.T., Realty Stocks; FPIs Stay Net Sellers
Live updates from India's equity markets on Oct. 11.
-
Panacea Biotec Hits Upper Circuit After Winning Rs 1,000-Crore Vaccine Order
Panacea Biotec has bagged orders worth Rs 1,040 crore from the Unicef and Pan American Health Organization.
-
Panacea Biotec Hits Upper Circuit After Winning Rs 1,000-Crore Vaccine Order
Panacea Biotec has bagged orders worth Rs 1,040 crore from the Unicef and Pan American Health Organization.
-
Panacea Biotec Shares Gain On Sale Of Domestic Formulations Brands To Mankind
Panacea Biotec Pharma has agreed to sell its formulations brands in India and Nepal to Mankind.
-
Panacea Biotec Rallies 9% On Receiving License To Produce Sputnik V Vaccine
The Sputnik V vaccine will be produced at Panacea Biotec's Baddi manufacturing facility in Himachal Pradesh.
